| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Sportpharm LLC | ddbc3bf6-5bab-4851-ae5a-ef263cd8f255 | 2026-07-23 | Warnings, Adverse reactions | Exact identifier application number: ANDA065169 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE | WG Critical Care, LLC | 86ec0a92-a552-4a6d-9125-a54f95e43392 | 2026-06-18 | Warnings, Adverse reactions | Exact identifier unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Sportpharm LLC | 85ce4f8b-77e0-48bf-9f57-93f1478befa2 | 2026-04-24 | Warnings, Adverse reactions | Exact identifier rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Sportpharm LLC | 9a937e47-8c36-4656-83e1-b3c18ed9bac3 | 2026-04-24 | Warnings, Adverse reactions | Exact identifier rxcui: 1665005 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | REMEDYREPACK INC. | 9c801096-ca61-4b29-a1e1-5f7e7813b191 | 2026-02-06 | Warnings, Adverse reactions | Exact identifier application number: ANDA065169 rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Qilu Pharmaceutical Co., Ltd. | 4cdf0743-c62b-4969-b9c9-4c6400644f6c | 2026-02-04 | Warnings, Adverse reactions | Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 128bb292-d174-4769-b3e6-9f16617f31e3 | 2026-01-22 | Warnings, Adverse reactions | Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 19141ccd-e66c-49a2-a794-0616028495a7 | 2026-01-19 | Warnings, Adverse reactions | Exact identifier application number: ANDA065169 ndc (package): 0409-7338-20 ndc (package): 0409-7338-21 ndc (package): 0409-7332-21 ndc (package): 0409-7335-21 ndc (package): 0409-7332-20 ndc (package): 0409-7337-20 ndc (package): 0409-7335-20 ndc (package): 0409-7337-21 ndc (product): 0409-7338 ndc (product): 0409-7335 ndc (product): 0409-7332 ndc (product): 0409-7337 ndc11 (package): 00409733821 rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 spl id: c4d53472-41a6-428e-8935-f2c611729457 spl set id: 19141ccd-e66c-49a2-a794-0616028495a7 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 03283208-8616-4117-9d2b-aa8046017a4f | 2026-01-19 | Warnings, Adverse reactions | Exact identifier application number: ANDA065169 ndc (package): 0409-7338-11 ndc (package): 0409-7337-01 ndc (package): 0409-7337-11 ndc (package): 0409-7335-03 ndc (package): 0409-7332-01 ndc (package): 0409-7332-11 ndc (package): 0409-7338-01 ndc (package): 0409-7335-13 ndc (product): 0409-7338 ndc (product): 0409-7335 ndc (product): 0409-7332 ndc (product): 0409-7337 rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 spl id: cc7743b1-4e7b-446a-9ec1-cc234a8bbccf spl set id: 03283208-8616-4117-9d2b-aa8046017a4f unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 365fc265-8e6c-432f-9fda-911f5f7fb451 | 2026-01-16 | Warnings, Adverse reactions | Exact identifier unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 36c07ebf-b091-483e-b2c4-f0fc0c2b4186 | 2026-01-16 | Warnings, Adverse reactions | Exact identifier unii: 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE | WG Critical Care, LLC | 7bed9b33-29e3-4f04-9766-43a21c7ad47a | 2026-01-07 | Warnings, Adverse reactions | Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE | WG Critical Care, LLC | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 2025-04-07 | Warnings, Adverse reactions | Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Sandoz Inc | 53df951b-2eee-44b1-bae2-df7ed85bc0ed | 2025-02-28 | Warnings, Adverse reactions | Exact identifier unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Sandoz Inc | de028434-46cf-44f6-8ac6-889c7c6943b3 | 2025-02-27 | Warnings, Adverse reactions | Exact identifier application number: ANDA065169 rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE SODIUM | Baxter Healthcare Company | 4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1 | 2024-10-07 | Warnings, Adverse reactions | Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | A-S Medication Solutions | 53415af6-4072-4339-83e2-d870ae02a0e2 | 2024-08-20 | Warnings, Adverse reactions | Exact identifier rxcui: 1665005 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | A-S Medication Solutions | b642877e-0d36-4218-afe9-0a39f35b571d | 2024-03-27 | Warnings, Adverse reactions | Exact identifier application number: ANDA065169 ndc (package): 50090-0944-0 ndc (product): 50090-0944 rxcui: 1665005 spl id: aec67c2e-94ef-4be6-afb1-d5c47bbdfad1 spl set id: b642877e-0d36-4218-afe9-0a39f35b571d unii: 023Z5BR09K |
| Ceftriaxone | CEFTRIAXONE | Civica, Inc. | 96f3fc1e-84f4-4e9b-91ac-19a1692f227a | 2024-02-06 | Warnings, Adverse reactions | Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Proficient Rx LP | 790279d4-2456-4091-abec-960b78885432 | 2024-02-01 | Warnings, Adverse reactions | Exact identifier rxcui: 1665005 unii: 023Z5BR09K |